Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1906 AL 1920

Alzheimer's Disease and (Phyto) Estrogen Treatment: Modification of Effects by Age, Type of Treatment, and Duration of Use

Kuck MJ, Begde A, Hawkins K, Hogervorst E.

J Alzheimers Dis. 2024;101(s1):S217-S234. doi: 10.3233/JAD-231415.

Targeting Metals in Alzheimer's Disease: An Update

Du B, Chen K, Wang W, Lei P.

J Alzheimers Dis. 2024;101(s1):S141-S154. doi: 10.3233/JAD-240140.

Ketogenic Approaches for the Treatment of Alzheimer's Disease

Gabuzyan R, Lee C, Nygaard HB.

J Alzheimers Dis. 2024;101(s1):S443-S453. doi: 10.3233/JAD-240186.

Amyloid-Directed Antibodies: Past, Present, and Future

Noorda K, Noorda K, Sabbagh MN, Bertelson J, Singer J, Decourt B.

J Alzheimers Dis. 2024;101(s1):S3-S22. doi: 10.3233/JAD-240189.

Genistein, A Phytoestrogen, Delays the Transition to Dementia in Prodromal Alzheimer's Disease Patients

Viña J, Borrás C, Mas-Bargues C.

J Alzheimers Dis. 2024;101(s1):S275-S283. doi: 10.3233/JAD-240308.

Hypercholesterolemia and Alzheimer's Disease: Unraveling the Connection and Assessing the Efficacy of Lipid-Lowering Therapies

Pappolla MA, Refolo L, Sambamurti K, Zambon D, Duff K.

J Alzheimers Dis. 2024;101(s1):S371-S393. doi: 10.3233/JAD-240388.

Treating Alzheimer's Disease: Focusing on Neurodegenerative Consequences

Sun MK, Alkon DL.

J Alzheimers Dis. 2024;101(s1):S263-S274. doi: 10.3233/JAD-240479.

Metformin as a Potential Prevention Strategy for Alzheimer's Disease and Alzheimer's Disease Related Dementias

Tahmi M, Benitez R, Luchsinger JA.

J Alzheimers Dis. 2024;101(s1):S345-S356. doi: 10.3233/JAD-240495.

Growth Factor Gene Therapy for Alzheimer's Disease

Tuszynski MH.

J Alzheimers Dis. 2024;101(s1):S433-S441. doi: 10.3233/JAD-240545.

Oxidative Stress in Alzheimer's Disease: The Shortcomings of Antioxidant Therapies

Pappolla MA, Martins RN, Poeggeler B, Omar RA, Perry G.

J Alzheimers Dis. 2024;101(s1):S155-S178. doi: 10.3233/JAD-240659.

Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use

Sayfullaeva J, McLoughlin J, Kwakowsky A.

J Alzheimers Dis. 2024;101(s1):S235-S261. doi: 10.3233/JAD-240899.

A systematic review of the efficacy and safety of anti-amyloid beta monoclonal antibodies in treatment of Alzheimer's disease

Chhabra A, Solanki S, Saravanabawan P, Venkiteswaran A, Nimmathota N, Modi NM.

Expert Opin Biol Ther. 2024 Nov;24(11):1261-1269. doi: 10.1080/14712598.2024.2416947. Epub 2024 Nov 12.

Surface engineered nano architectonics: An evolving paradigm for tackling Alzheimer's disease

Negi M, Amulya E, Phatale V, Abraham N, Hedaoo A, Srinivasarao DA, Srivastava S.

Life Sci. 2024 Dec 1;358:123155. doi: 10.1016/j.lfs.2024.123155. Epub 2024 Oct 19.

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy

Batra R, Krumsiek J, Wang X, Allen M, Blach C, Kastenmüller G, Arnold M, Ertekin-Taner N, Kaddurah-Daouk R; Alzheimer's Disease Metabolomics Consortium (ADMC).

Alzheimers Dement. 2024 Dec;20(12):8294-8307. doi: 10.1002/alz.14249. Epub 2024 Oct 22.

Gut microbiome-derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeutics

Chandra S, Vassar RJ.

Immunol Rev. 2024 Oct;327(1):33-42. doi: 10.1111/imr.13412. Epub 2024 Oct 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias